BRD-K78485176-001-03-7 (Substance)

Compound:

OLMESARTAN MEDOXOMIL

Synonyms:BRD-K78485176-001-03-7

Id:375174744

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K78485176-001-03-7's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC REP.A024 HT29 24H M12 olmesartan-medoxomil 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 REP.A024 HT29 24H M11 olmesartan-medoxomil 0.125uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A024 THP1 24H M10 olmesartan-medoxomil 0.37uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A024 JURKAT 24H M12 olmesartan-medoxomil 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A024 HELA 24H M09 olmesartan-medoxomil 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 CPC004 PC3 6H N14 olmesartan-medoxomil 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B024 MCF10A 24H M08 olmesartan-medoxomil 0.74uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A024 JURKAT 24H M07 olmesartan-medoxomil 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A024 MCF7 24H M08 olmesartan-medoxomil 3.33uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A024 THP1 24H M07 olmesartan-medoxomil 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC REP.A024 HT29 24H M12 olmesartan-medoxomil 0.04um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC 2021 REP.A024 HT29 24H M11 olmesartan-medoxomil 0.125uM

Biosample (Entity type)